Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

TransMedics (TMDX) Other financing activities (2019 - 2025)

TransMedics has reported Other financing activities over the past 3 years, most recently at $138000.0 for Q3 2025.

  • Quarterly results put Other financing activities at $138000.0 for Q3 2025, changed N/A from a year ago — trailing twelve months through Sep 2025 was $723000.0 (changed N/A YoY), and the annual figure for FY2020 was $705000.0, down 85.45%.
  • Other financing activities for Q3 2025 was $138000.0 at TransMedics, down from $366000.0 in the prior quarter.
  • Over the last five years, Other financing activities for TMDX hit a ceiling of $138000.0 in Q3 2025 and a floor of $138000.0 in Q3 2025.